Key recommendations from industry body for advanced manufacturing in India’s next budget
The Confederation of Indian Industry (CII) subsidiary Esocam has laid out a comprehensive roadmap for the upcoming 2027‑28 Union Budget, emphasizing advanced manufacturing as a priority area. Central to its plan is the introduction of a specialised Production‑Linked Incentive scheme aimed at the robotics ecosystem, including automation tools, sensor technologies and high‑precision components.
According to Esocam, achieving the target of a 25 percent contribution of manufacturing to the nation’s GDP hinges on reinforcing current PLI initiatives. The organization proposes that sectors leveraging cutting‑edge technologies receive extra policy incentives to drive indigenous production and reduce import dependence.
The proposal extends to other strategic verticals such as specialty steel, textile manufacturing, white‑goods production, ACC battery technology and solar photovoltaic modules. Esocam recommends streamlining the approval process, ensuring prompt disbursement of incentive amounts and monitoring implementation rigorously.
In the realm of research and development, the body advocates reinstating tax relief measures that were previously effective. These include a weighted 200 percent deduction on qualified R&D expenditure, a full 100 percent deduction on eligible capital outlays, customs duty waivers on scientific instruments, rapid depreciation schedules and tax holidays for recognised research firms. Reviving these benefits, Esocam asserts, will fuel innovation, attract private capital and enhance India's technological self‑reliance.
The association also addresses the electric vehicle sector, proposing that EVs be allowed to register and secure financing without an attached battery—thereby lowering entry barriers. For MSME fleet operators, a three‑percent interest subsidy and an extended financing window of seven to eight years are suggested to match typical battery warranty timelines.
Lastly, Esocam urges the creation of a dedicated clinical research framework for Ayurveda and AYUSH, supported by government grants and financial aid. Such a programme would validate traditional health products scientifically and promote their export potential.